
Dr. James Mandigo appointed new President and Vice-Chancellor of the University of the Fraser Valley
As Mandigo takes the reins from recently retired Dr. Joanne MacLean and becomes UFV's seventh president, he brings a wealth of relevant experience gleaned from his time in administration at UFV: five years as provost and vice-president, academic, and one year as interim president.
"I am leading an exceptional team of faculty and staff, and together we're going to continue building on the foundation that Joanne put in place," Mandigo said.
Throughout his career, Mandigo has shown a desire to address social issues, and he's been a champion of UFV's community-focused approach since arriving as provost and vice-president, academic in 2019.
"It's in the DNA of UFV to be a changemaking institution, and I'm truly struck by how well the university fosters collaborative relationships within the communities that we serve," Mandigo says. "Our students, faculty, staff, alumni and volunteers have so many gifts to share. Collectively, we have great potential to be agents of change positively impacting the socio-cultural and economic development of our communities."
While Mandigo encourages changemaking across all UFV disciplines, his own work has often focused on the benefits of active living among youth.
He spent nearly 20 years at Ontario's Brock University before joining UFV. During that time, he conducted vital research exploring ways to use sport and physical education to develop life skills to prevent violence amongst children and youth in El Salvador and Guatemala. His collaborative work with Universidad Pedagogica earned him formal recognition by the government of El Salvador.
He's also been a visiting scholar at the University of Tsukuba's International Academy for Sports Studies in Japan and provided a leadership role with the Scotiabank Champions for Health Promoting Schools in the Caribbean islands of St. Vincent, Antigua, and British Virgin Islands.
In 2015, Mandigo received Canada's Physical and Health Education's most prestigious award, the R. Tait McKenzie Award.
"Sports are one way to effect meaningful change, and our students and faculty at UFV prove every day that there are many, many more ways to do so," he says. "I love the creativity that we bring to address issues like food and housing security, climate change resilience, and other pressing concerns. Part of my new role is to encourage innovation and foster an environment where our researchers are free to think outside the box and become changemakers."
Mandigo has published 43 peer-reviewed articles and several book chapters, along with a full book titled Healthy Schools, Healthy Futures. His work has been funded by organizations including the Social Science and Humanities Research Council, the International Olympic Committee's Olympic Studies Centre, and Scotiabank International.
Mandigo holds a PhD from the University of Alberta in Physical Education and Recreation, a Master of Arts in Child and Development Studies from Laurentian University, and a Bachelor of Arts in Physical Education from Wilfrid Laurier University.
Before joining UFV in 2019, he held leadership roles at Brock University, including vice-provost, interim dean, and associate dean. He was also co-director for the Faculty of Health Sciences' Research Centre for Healthy Development through Sport and Physical Activity and held a faculty appointment in the Kinesiology department.
He served as UFV's interim president for one year while MacLean was managing health issues.
Over the last six years at UFV, he has played a pivotal role in the development of excellence in teaching, learning, scholarship, and service and has been a champion of UFV's One Health initiative.
Known for his warm and approachable leadership style, Mandigo looks forward to connecting with the university community in the days to come.
"Our faculty, employees, and students have unlimited potential to change the world," he says. "As we pursue excellence in the coming years, I'm excited to see what we'll accomplish together. I have every confidence that we will continue to engage learners, transform lives, and build community 50 years forward."
Mandigo's first day in his new role is July 1.
About UFV
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
2 hours ago
- Cision Canada
Public advisory - Unlicensed Mitolux UV sunlamps for Vitamin D may pose health risks Français
, /CNW/ - Summary Product: Unlicensed ultraviolet (UV) sunlamps Issue: Health products – Unauthorized product; Product safety What to do: Do not use unlicensed Mitolux UV sunlamps. Consult a health care professional if you have used any of these sunlamps and have concerns about your health. Check whether medical devices have been licensed for sale by searching Health Canada's Medical Devices Active Licence Listing. Report any health product-related side effects or complaints to Health Canada. Affected products Issue Health Canada is warning consumers that unlicensed ultraviolet (UV) sunlamps sold by Mitolux may pose health risks due to excessive and unsafe ultraviolet B (UVB) radiation levels. The devices are marketed to be a reliable source of natural Vitamin D. Too much exposure to UVB radiation from using Mitolux UV sunlamps can cause: skin reactions and burns eye damage premature skin aging skin cancer with repeated exposure It is illegal to advertise for sale, import for sale, or sell medical devices in Canada without appropriate licensing under the Medical Devices Regulations. Health Canada is asking companies that sell Mitolux UV sunlamps to immediately stop selling them. Should additional safety concerns be identified, Health Canada will take appropriate action to protect public health and safety, including communicating updates, if needed. What you should do


Cision Canada
4 hours ago
- Cision Canada
BTL Expands EMFACE® Indications with New FDA Clearance for TMJ Dysfunction
BOSTON, Aug. 13, 2025 /CNW/ -- BTL Industries, a global leader in medical and wellness technologies, has expanded the FDA-cleared applications of its EMFACE® platform with a new indication for the treatment of temporomandibular joint (TMJ) dysfunction. EMFACE® is now cleared by the FDA for the relief of symptoms associated with muscle spasm, treatment of TMJ dysfunction and associated pain, muscle re-education, increased local blood flow, and the maintenance or improvement of mandibular range of motion. Developed through years of research and engineering, EMFACE combines synchronized radiofrequency and HIFES® technology for facial muscle stimulation, delivering relief without surgery, injections, or medication. "EMFACE is an established technology platform with multiple FDA-cleared uses," said David Chmel, CEO of BTL Industries. "This new indication allows dental, oral health, and wellness providers to address TMJ dysfunction within its approved uses, expanding the benefits of EMFACE to more patients." "TMJ dysfunction impacts more than the jaw — it affects quality of life," said Shireen Dhanani, DMD, Leesburg, FL. "With EMFACE, we can now offer an accessible, non-invasive option that not only helps patients find relief and functional improvement, but also expands the scope of dental care." BTL continues to redefine what's possible in facial care and wellness, bringing science-backed technologies like EMFACE into new areas of medicine to improve lives and advance patient care worldwide. For more information about EMFACE, visit www. About BTL Industries Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. Operating in over 90 countries, BTL holds more than 200 patents and employs over 500 R&D engineers dedicated to advancing medical treatments through technology and science. Its product portfolio includes EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others.


Cision Canada
6 hours ago
- Cision Canada
New Study Demonstrates Superiority of EggNest™ Complete Radiation Protection System in Comprehensive Protection for the Entire Interventional Team
MINNEAPOLIS, Aug. 13, 2025 /CNW/ -- A recent study published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) highlights the effectiveness of the EggNest™ Complete radiation shielding system, demonstrating its superior ability to protect all personnel in the catheterization lab from scatter radiation. The findings show that while other next-generation systems offer protection for the primary operator and assistant, the EggNest™ Complete system provides significant protection for the entire interventional team. The study, titled "Comparative Effectiveness of 2 Next-Generation Scatter Radiation Shielding Systems," compared the EggNest™ Complete system with the Rampart IC system and a no-shielding condition using an anthropomorphic phantom. The results showed that both the EggNest™ Complete and Rampart IC systems significantly reduced radiation exposure for the operator and assistant positions compared to no shielding. However, the EggNest™ Complete system provided additional significant protection for staff at the head of the bed and the nursing positions, a benefit not observed with the Rampart IC system. "From the beginning, Egg Medical has had three guiding principles: we need to protect the entire team from scatter radiation, we can't interfere with workflow or patient access, and the reduction in radiation exposure must be nearly complete. The study by Riley et al shows very clearly that the EggNest Complete system dramatically reduces radiation exposure for everyone in the room, and that the operator and assistant are almost completely protected. That is a marked improvement to safety for everyone who works in x-ray guided procedures," said Dr. Robert Wilson, CEO of Egg Medical. The study's authors note that interventional cardiology procedures expose healthcare professionals to prolonged ionizing radiation, which poses significant health risks including heightened rates of malignancy, cataracts, and orthopedic injuries. Traditional lead aprons, while offering some protection, are heavy (up to 25 pounds) and can lead to musculoskeletal injuries. A recent SCAI survey found that 66% of operators reported musculoskeletal pain attributed to their time in the cardiac catheterization laboratory. "It's a community effort to bring the issue of healthcare worker safety to the forefront of our industry. We deserve the same level of protection we strive to give to patients. This study highlights that Egg Medical's EggNest Complete System sets a new standard for what ALARA (As Low As Reasonably Achievable) means today," said Robert Riley, MD, a co-author of the study. The study's findings indicate that a comprehensive shielding system like EggNest™ Complete is crucial for ensuring the safety of all interventional lab personnel, including operators, assistants, nurses, and other staff. This is particularly important for complex procedures where staff may be positioned in areas with limited traditional shielding and higher cumulative exposure. The authors of a separate commentary on the study commended the findings, emphasizing that these results align with the Society for Cardiovascular Angiography & Interventions' mission to advance occupational safety and are essential for sustaining the interventional cardiology workforce. Comparative Effectiveness of 2 Next-Generation Scatter Radiation Shielding Systems. Stephen Kidd, MD, Robert F. Riley, MD, MS, Juliette Power, MD, Brian Stegman, MD, Thom G. Dahle, MD. Division of Cardiology, Overlake Medical Center, Bellevue, Washington. Division of Cardiology, St. Cloud Hospital, St. Cloud, Minnesota. Journal of the Society for Cardiovascular Angiography & Interventions (2025), doi: About Egg Medical Egg Medical is a global leader in radiation protection technologies. Headquartered in Minnesota, the company was founded with the goal to reduce the scatter radiation exposure of physicians, surgeons, nurses, technicians and others who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients. More information about Egg Medical is available at